新開源(300109.SZ):終止非公開發行股票募集配套資金
格隆匯 3 月 10日丨新開源(300109.SZ)公佈,公司於2019年5月8日收到中國證監會核發的《關於核准博愛新開源醫療科技集團股份有限公司向蕪湖長謙投資中心(有限合夥)等發行股份購買資產並募集配套資金的批覆》(證監許可[2019]848號),核准公司向蕪湖長謙投資中心(有限合夥)發行2458.5125萬股股份,向華融天澤投資有限公司發行2458.5125萬股股份,向廣州君澤股權投資管理合夥企業(有限合夥)發行1229.2562萬股股份,向天津同歷並贏二號企業管理諮詢中心(有限合夥)發行1229.2562萬股股份,向趙天發行1843.8844萬股股份,向胡兵來發行1229.2562萬股股份購買相關資產。及核准公司非公開發行股份募集配套資金不超過5.6億元。
公司董事會現決定終止此次非公開發行股票募集配套資金。
截至目前,鑑於資本市場環境等因素髮生了較大變化,綜合考慮公司業務發展規劃、資本市場狀況、融資可行性等因素,經過審慎研究,公司決定終止此次非公開發行股票募集配套資金事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.